25.03
Zymeworks Bc Inc Borsa (ZYME) Ultime notizie
Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results - GlobeNewswire Inc.
Zymeworks EVP Schayowitz sells $357,557 in shares By Investing.com - Investing.com Nigeria
Diluted shares outstanding of Zymeworks Inc. – HAN:ZA8 - TradingView
Form 4 Zymeworks Inc For: 12 October By Investing.com - Investing.com Nigeria
Zymeworks EVP Adam Schayowitz sells $357,557 in shares - Investing.com
Zymeworks EVP Adam Schayowitz sells $357,557 in ZYME stock for taxes - Investing.com
Zymeworks EVP, head of R&D Adam Schayowitz sells $357,557 in stock. - Investing.com
Form 4 Zymeworks Inc For: 9 October By Investing.com - Investing.com South Africa
Zymeworks (NASDAQ:ZYME) Stock: Insider Adam Schayowitz Sells 13,832 Shares - MarketBeat
A mandatory sale covers taxes: Zymeworks (ZYME) R&D head sells 13,832 shares at $25.85. - Stock Titan
Form 144 Zymeworks Inc. For: 9 October By Investing.com - Investing.com Nigeria
Officer Adam Schayowitz proposes selling 13,832 shares of Zymeworks (Nasdaq: ZYME). - Stock Titan
Jefferies keeps Buy on Zymeworks stock at USD 50 target - AD HOC NEWS
Zymeworks stock fell 2.14 percent as 2026 guidance reset - AD HOC NEWS
Zymeworks Completes Theravance Deal, Adds YUPELRI Cash Flow and Raises 2026 Outlook - TradingView
Zymeworks Completes Theravance Deal, Adds YUPELRI Cash Flow and Raises 2026 Outlook - Yahoo Finance
EBIT per share of Zymeworks Inc. – HAN:ZA8 - TradingView
CapEx per share of Zymeworks Inc. – HAN:ZA8 - TradingView
Taxes of Zymeworks Inc. – HAN:ZA8 - TradingView
Zymeworks stock coverage reinstated at Buy by TD Cowen on acquisition - Investing.com Nigeria
Citigroup keeps 'Buy' on Zymeworks after acquis... - Pluang
Zymeworks stock coverage reinstated at Buy by TD Cowen on acquisition - Investing.com Canada
Dilution adjustment of Zymeworks Inc. – HAN:ZA8 - TradingView
Zymeworks Inc. (ZYME) stock price, news, quote and history - Yahoo Finance UK
Zymeworks (ZYME) Completes Theravance Biopharma Acquisition, Eyes Growth in COPD Market - GuruFocus
Zymeworks Updates Annual Financial Targets After Finalizing Theravance Biopharma Deal - TradingView
Zymeworks Updates Annual Financial Targets After Finalizing Theravance Biopharma Deal - Benzinga
Zymeworks Completes Theravance Acquisition Deal - grafa.com
Zymeworks Inc. Updates Earnings Guidance for the Year 2026 - marketscreener.com
Zymeworks Inc. Updates Earnings Guidance for the Year 2026 - marketscreener.com
Zymeworks Inc. (ZYME) Theravance Biopharma, Inc.M&A CallSlideshow (NASDAQ:ZYME) 2026-09-28 - Seeking Alpha
Zymeworks Inc. and Theravance Biopharma, Inc. Acquisition Call Transcript - GuruFocus
Zymeworks (ZYME) Completes Theravance Biopharma Acquisition, Int - GuruFocus
Zymeworks Inc Expects Total Revenue, Including Collaboration Revenue From Yupelri, For 2026 To Be Between $278 Million And $292 Million - TradingView
Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition - GlobeNewswire Inc.
Zymeworks Announces Updated 2026 Financial Guidance and - GlobeNewswire
Bank of America Corp DE Buys 219,071 Shares of Zymeworks Inc. $ZYME - MarketBeat
Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition - Yahoo Finance
Vancouver biotech Zymeworks closes US$929M Theravance deal - Business in Vancouver
A $350 million debt issue helped fund Zymeworks (ZYME)'s Theravance acquisition, with cash due per eligible share. - Stock Titan
Zymeworks Completes Acquisition of Theravance Biopharma - GlobeNewswire
Zymeworks Completes Acquisition of Theravance Biopharma - Yahoo Finance
Squarepoint Ops LLC Reduces Holdings in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks' Theravance Deal Is A Breath Of Fresh Cash Flow (NASDAQ:ZYME) - Seeking Alpha
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 238,026 Shares of Zymeworks Inc. $ZYME - MarketBeat
Wellington Management Group LLP Takes $2.88 Million Position in Zymeworks Inc. $ZYME - MarketBeat
Legal & General Group Plc Makes New $1.13 Million Investment in Zymeworks Inc. $ZYME - MarketBeat
Bank of New York Mellon Corp Acquires New Holdings in Zymeworks Inc. $ZYME - MarketBeat
JPMorgan Chase & Co. Boosts Zymeworks (NASDAQ:ZYME) Price Target to $33.00 - MarketBeat
Zymeworks (NASDAQ:ZYME) Hits New 1-Year HighTime to Buy? - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):